Paul Alloway's Net Worth

$32.1 Thousand

Estimate Recalculated Apr 23, 2024 04:03PM EST

Who is Paul Alloway?

Paul Alloway does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Homology Medicines, Inc..

SEC CIK

Paul Alloway's CIK is 0001916155

Past Insider Trading and Trends

2023 was Paul Alloway's most active year for acquiring shares with 4 total transactions. Paul Alloway's most active month to acquire stocks was the month of December. 2023 was Paul Alloway's most active year for disposing of shares, totalling 4 transactions. Paul Alloway's most active month to dispose stocks was the month of December. 2023 saw Paul Alloway paying a total of $0.00 for 200,570 shares, this is the most they've acquired in one year. In 2023 Paul Alloway cashed out on 23,625 shares for a total of $20,159.10, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Q32 Bio Inc. (FIXX) Snapshot price: $0.715

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-9.36%
-268.00
$24.21
-$6,488.28
2.6K
Mar 25
Form 4
+83.93%
23.53K
—
—
51.57K
Mar 25
Form 4
-20.61%
-7.28K
$0.57
-$4,120.48
28.04K
Jan 3
Form 4
+111.40%
18.61K
—
—
35.32K
Jan 1
Form 4
-39.63%
-10.96K
$1.45
-$15,863.07
16.71K
Scheduled
Mar 2
Form 4
—
0
—
—
0
Feb 23
Form 4/A
—
0
—
—
0
Form 4
-13.32%
-3.09K
$1.39
-$4,296.03
20.1K
Scheduled
Jan 9
Form 4
+70.25%
9.57K
—
—
23.19K
Jan 1
Form 3
—
0
—
—
0
No matching records found